Practical implication
Suppliers must implement new protocols for safety reporting and record-keeping as per the proposed framework.
The Health Sciences Authority (HSA) of Singapore has opened a consultation on a proposed regulatory framework aimed at enhancing the safety and quality oversight of Complementary Health Products (CHP). This includes new mandatory requirements for Product Notification, Record Keeping, and Safety Reporting. The deadline for feedback is July 29, 2026.
What changed: New mandatory safety reporting and record-keeping requirements for suppliers of Complementary Health Products (CHPs) in Singapore are proposed under the Health Products Act.
Why it matters: These requirements will strengthen the oversight of CHP products, ensuring better safety and quality standards which could impact compliance workflows for suppliers.
Practical implication: Suppliers must implement new protocols for safety reporting and record-keeping as per the proposed framework.
View original source
Published from the Firecrawl policy change extraction pipeline.